CDP‐choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement
Authors:
- 30 July 2004
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 18 (5) , 513-523
Abstract
In the present study, we investigated the effect of intracerebroventricular (i.c.v.) administration of cytidine‐5′‐diphosphate (CDP) choline on plasma adrenocorticotropin (ACTH), serum growth hormone (GH), thyroid stimulating hormone (TSH), follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels in conscious rats. The involvement of cholinergic mechanisms in these effects was also determined. In basal conditions, CDP‐choline (0.5, 1.0 and 2.0 μmol, i.c.v.) increased plasma ACTH levels dose‐ and time‐dependently, but it did not affect the TSH, GH, FSH and LH levels. In stimulated conditions, i.c.v. administration of CDP‐choline (1 μmol, i.c.v.) produced an increase in clonidine‐stimulated GH, thyrotyropin‐releasing hormone (TRH)‐stimulated TSH, LH‐releasing hormone (LHRH)‐stimulated LH, but not FSH levels. Injection of equimolar dose of choline (1 μmol, i.c.v.) produced similar effects on hormone levels, but cytidine (1 μmol, i.c.v.) failed to alter plasma levels of these hormones. Pretreatment with hemicholinium‐3, a neuronal high affinity choline uptake inhibitor, (20 μg, i.c.v.) completely blocked the observed hormone responses to CDP‐choline. The increase in plasma ACTH levels induced by CDP‐choline (1 μmol, i.c.v.) was abolished by pretreatment with mecamylamine, a nicotinic receptor antagonist, (50 μg, i.c.v.) but not atropine, a muscarinic receptor antagonist, (10 μg, i.c.v.). The increase in stimulated levels of serum TSH by CDP‐choline (1 μmol, i.c.v.) was blocked by atropine but not by mecamylamine pretreatment. However, CDP‐choline induced increases in serum GH and LH levels were greatly attenuated by both atropine and mecamylamine pretreatments. The results show that CDP‐choline can increase plasma ACTH and produce additional increases in serum levels of TSH, GH and LH stimulated by TRH, clonidine and LHRH, respectively. The activation of central cholinergic system, mainly through the presynaptic mechanisms, was involved in these effects. Central nicotinic receptors solely mediated the increase in plasma ACTH levels while the activation of central muscarinic receptors was involved in the increase in TSH levels. Both muscarinic and nicotinic receptor activations, separately, mediated the increases in serum GH and LH levels after CDP‐choline.Keywords
This publication has 38 references indexed in Scilit:
- Role of α7 Nicotinic Acetylcholine Receptors in the Pressor Response to Intracerebroventricular Injection of Choline: Blockade by Amyloid Peptide Aβ1-42The Journal of Pharmacology and Experimental Therapeutics, 2004
- Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?Mechanisms of Ageing and Development, 2001
- Choline and acetylcholine have similar kinetic properties of activation and desensitization on the α7 nicotinic receptors in rat hippocampal neuronsBrain Research, 2000
- Muscarinic Regulation of Intracellular Signaling and Neurosecretion in Gonadotropin-Releasing Hormone NeuronsEndocrinology, 1998
- Metabolism and actions of cdpcholine as an endogenous compound and administered exogenously as citicolineLife Sciences, 1995
- Effect of Cytidine on Membrane Phospholipid Synthesis in Rat Striatal SlicesJournal of Neurochemistry, 1995
- Effects of Intracerebroventricular Injected Choline on Cardiovascular Functions and Sympathoadrenal ActivityJournal of Cardiovascular Pharmacology, 1991
- Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatinJournal of Endocrinology, 1986
- Choline Administration: Activation of Tyrosine Hydroxylase in Dopaminergic Neurons of Rat BrainScience, 1976
- Evidence for a Cholinergic Component in the Neuroendocrine Control of Luteinizing Hormone (LH) SecretionNeuroendocrinology, 1975